Atlanta Braves Slugger Jurickson Profar Hit With 162-Game PED Suspension
Major League Baseball has delivered a severe blow to Atlanta Braves designated hitter Jurickson Profar, who has tested positive for performance-enhancing drugs for the second time in his career. This repeat offense triggers an automatic 162-game suspension under MLB's strengthened drug policy, meaning Profar could miss the entire 2026 regular season.
Financial and Competitive Consequences Mount for Repeat Offender
According to ESPN reports, the 33-year-old veteran will forfeit his entire $15 million salary for the suspended season. Furthermore, Profar will be ineligible to participate in postseason play, even if the Atlanta Braves qualify for the playoffs. This disciplinary action arrives at an especially unfortunate time, as Profar was poised to join the Netherlands national team for the upcoming World Baseball Classic.
Instead of representing his country on the international stage, Profar now confronts another monumental career setback. The timing compounds the disappointment for both the player and the organization, which had counted on his offensive production.
History of Violations and Previous Statements
This marks the second PED-related suspension for Jurickson Profar within a short timeframe. He previously served an 80-game suspension early in the 2025 season. Following that initial ban, Profar issued a comprehensive statement expressing his remorse.
"It is because of my deep love and respect for this game that I would never knowingly do anything to cheat it," Profar declared at the time.
The Atlanta Braves organization responded to that first incident with a mixture of surprise and disappointment, while affirming their support for MLB's drug program. "We were surprised and extremely disappointed," team officials stated, adding that they "fully support the program and are hopeful Jurickson will learn from this experience."
To date, Profar has not made any public comments regarding this latest, more severe suspension.
Braves' Roster Takes Another Hit Amid Injury Woes
The loss of Profar's bat creates significant challenges for the Atlanta Braves lineup, particularly as the team already grapples with multiple pitching injuries. Starting pitchers Spencer Schwellenbach and Hurston Waldrep are both sidelined with elbow issues, thinning the rotation.
Profar himself was in a recovery phase, having recently returned from sports hernia surgery. The Braves had planned to utilize him primarily as a designated hitter this season to manage his workload. Manager Walt Weiss must now reconfigure his offensive strategy and lineup construction without a key middle-of-the-order presence.
Contract Details and Future Implications
Jurickson Profar signed a substantial $42 million contract with the Atlanta Braves in January 2025, following an All-Star season with the San Diego Padres in 2024. Atlanta's front office believed they were acquiring a reliable, veteran bat to anchor the top of their batting order.
During his last full season, Profar posted a .245 batting average with a .353 on-base percentage and .434 slugging percentage, contributing 14 home runs. His absence creates a substantial offensive void that the Braves must address through internal options or external acquisitions.
The 162-game suspension stems from MLB's enhanced Joint Drug Prevention and Treatment Program, which was fortified in 2014 to impose stricter penalties on repeat offenders. Profar becomes just the sixth player in Major League Baseball to receive this maximum-level punishment under the updated policy.
When Profar eventually becomes eligible to return in 2027, he will have one remaining year on his current contract, scheduled to earn another $15 million. However, his long-term future with the Braves organization now appears uncertain following this second serious violation of league policy.
